Eneboparatide for treating chronic hypoparathyroidism [ID6532]

  • Awaiting development
  • GID-TA11688
  • Expected publication date: TBC

Suggested remit: To appraise the clinical and cost effectiveness of Eneboparatide within its marketing authorisation for treating chronic hypoparathyroidism